Maxwell D. Cummings - Concepedia

Author

Maxwell D. Cummings

Also Known As

Cummings, M.D., Cummings, Maxwell David., M. D. CUMMINGS, M. D. Cummings, M.D. Cummings, Maxwell Cummings, Maxwell D. Cummings, Maxwell D. Cummings

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)Johnson & Johnson (United States)Janssen (Belgium)Springhouse University of Alberta

About

Maxwell D. Cummings is an author at Janssen (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	36	2.8K
2	Natural Sciences	18	22	2.1K
3	Biochemistry	16	18	1.5K
4	Biomolecular Engineering	7	7	762
5	Engineering	2	2	53

Maxwell D. Cummings

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Structure of the Shiga-like Toxin I B-Pentamer Complexed with an Analogue of Its Receptor Gb<sub>3</sub><sup>,</sup> Hong Ling, Amechand Boodhoo, Bart Hazes, Biochemistry	1998	425
Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells Bruce Grasberger, Tianbao Lu, Carsten J. Schubert, Journal of Medicinal Chemistry Molecular BiologyChemical BiologyPharmaceutical ChemistryTumor BiologyMolecular Pharmacology	2005	425
Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance S. Hare, Ann Vos, R. Clayton, Proceedings of the National Academy of Sciences Viral ReplicationHiv IntegraseImmunologyMolecular BiologyAntiviral Drug	2010	299
Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation Pejman Soroosh, Jiejun Wu, Xiaohua Xue, Proceedings of the National Academy of Sciences Lipid PeroxidationImmune RegulationImmunologyInnate ImmunityRedox Biology	2014	242
Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor Åsa Rosenquist, Bertil Samuelsson, Per-Ola Johansson, Journal of Medicinal Chemistry Hepatitis C VirusImmunologyPharmacotherapyImmunotherapeuticsAntiviral Drug	2014	211
<i>In Vitro</i> Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435 Oliver Lenz, Thierry Verbinnen, Tse‐I Lin, Antimicrobial Agents and Chemotherapy Molecular VirologyViral HepatitisPathogenesisImmunologyHcv Genotype 1	2010	210
Comparison of Automated Docking Programs as Virtual Screening Tools Maxwell D. Cummings, Renée L. DesJarlais, Alan C. Gibbs, Journal of Medicinal Chemistry	2005	205
1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR Daniel J. Parks, Louis V. LaFrance, Raul R. Calvo, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyDrug TargetSmall Molecule AntagonistsMedicineNatural Sciences	2004	166
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation <i>in vitro</i> and sensitize tumors to doxorubicin <i>in vivo</i> Holly K. Koblish, Shuyuan Zhao, Carol F. Franks, Molecular Cancer Therapeutics P53 InteractionChemoprevention StrategyP53 ComplexTumor BiologyMedicinal Chemistry	2006	162
Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase P.A. Elkins, Yen Sen Ho, Ward W. Smith, Acta Crystallographica Section D Biological Crystallography	2002	154

Page 1